Authors: Graziano, SL Tatum, A Herndon, JE Box, J Memoli, V Greene, MR Kern, JA

Citation: Sl. Graziano et al., Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study, LUNG CANC, 33(2-3), 2001, pp. 115-123